Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Historical Acquisition Tree
m-vax (1 trial)
autologous, dnp-modified melanoma vaccine (1 trial)
autologous, dnp-modified vaccine (1 trial)
autologous tumor cell vaccine (1 trial)
bacille calmette-guerin (1 trial)
cyclophosphamide (cytoxan) (1 trial)
l-vax (1 trial)
ofloxacin (floxin) (1 trial)
Adenocarcinoma (Phase 2)
Carcinoma, Non-Small-Cell Lung (Phase 2)
Carcinoma, Ovarian Epithelial (Phase 2)
Lung Neoplasms (Phase 2)
Melanoma (Phase 3)
Ovarian Neoplasms (Phase 2)
Trials (5 total)
Trial APIs (8 total)